Abhinav Kumar Nadipalli

Abhinav Kumar Nadipalli practices at Presbyterian Hospital in Albuquerque, New Mexico, part of Presbyterian Healthcare Services.

Abhinav Kumar Nadipalli's NPI, 1841711397, was assigned on July 5, 2017. Abhinav Kumar Nadipalli holds Illinois license 125.070297.

Abhinav Kumar Nadipalli's primary practice is Presbyterian Hospital, at 1100 Central Avenue SE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 724-8386.

Abhinav Kumar Nadipalli's primary practice is Presbyterian Hospital in Albuquerque, New Mexico, part of Presbyterian Healthcare Services. The medical group on file is Presbyterian Medical Group. Dmand AI also links Abhinav Kumar Nadipalli to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Abhinav Kumar Nadipalli practices. Vendor and product names are available with a free account.

Internal medicine is Abhinav Kumar Nadipalli's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Abhinav Kumar Nadipalli is licensed in Illinois.

CMS data shows 592 Medicare services from Abhinav Kumar Nadipalli across 4 procedure codes in 2024, for 201 Medicare patients. Medicare paid $38,649 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 201 Medicare patients who saw Abhinav Kumar Nadipalli in 2024. The largest group is 65 to 74, with 70 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 40% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Abhinav Kumar Nadipalli's median patient age at 66, with 48% women.

In 2024, Abhinav Kumar Nadipalli wrote 778 Medicare Part D claims for 227 patients. 86% of them were for generic drugs. CMS names the drug for 587 of them, across 26 drugs with 11 or more claims each, at $48,806 in total drug cost. In 2023, CMS named 505 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Abhinav Kumar Nadipalli for performance year 2024, reported as part of a group. Abhinav Kumar Nadipalli accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 19 general payments to Abhinav Kumar Nadipalli from 5 drug and device companies from 2020 to 2022. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $113.